Development and validation of UV-Spectrophotometric and RP-HPLC method for simultaneous estimation of Metformin and Doxycycline in bulk and synthetic mixture
Abstract
A simple, rapid, sensitive, accurate and precise UV spectrophotometric and isocratic RP-HPLC method have been developed for simultaneous estimation of Metformin and Doxycycline in bulk and synthetic mixture. Spectrophotometric estimation was done by two methods. First method was Q-absorbance ratio method, where two wavelengths 236 nm (λmax of Metformin) and 248 nm (Iso-absorptive point) were used. The second method was first derivative method. In this method the zero-crossing point of Metformin was selected at 282 nm and for Doxycycline, it was 232 nm. The solvent used was methanol in both the above UV-spectrophotometric methods. Metformin and Doxycycline showed good linearity in the series of 1-9 µg/ml and 2-20 µg/ml respectively by both the two methods with an excellent correlation coefficient (r2≥0.998). In RP-HPLC method, the chromatographic separation was achieved on Luna Phenomenex C18 (150 mmХ6 mm, 5 µm) analytical column. A mixture of Acetonitrile: Phosphate buffer (50 mM): Triethylamine (TEA): Tetrahydrofuran (THF) (30:66:2:2) pH adjusted to 2.1 with orthophosphoric acid was used as the mobile phase, at a flow rate of 1 ml/min and at detector wavelength 248 nm. The retention time of Metformin and Doxycycline was found to be 3.561±0.0017 and 5.574±0.0131 minutes respectively. A linear response was observed over the concentration range 4-64 µg/ml of Metformin and 5-80 µg/ml of Doxycycline. All the three methods were validated in accordance to ICH guidelines for linearity, accuracy, precision, LOD and LOQ. The proposed methods were effectively utilized for the concurrent estimation of Metformin and Doxycycline in synthetic mixture.
Keywords: Metformin, Doxycycline, Q-absorbance ratio method, First derivative method, RP-HPLC
Keywords:
Metformin, Doxycycline, Q-absorbance ratio method, First derivative method, RP-HPLCDOI
https://doi.org/10.22270/jddt.v11i4-S.4964References
Metformin hydrochloride | C4H12ClN5 - PubChem [Internet]. [cited 2021 Apr 26]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Metformin-hydrochloride
1115-70-4 | Metformin Hydrochloride | N,N-Dimethylimidodicarbonimidic Diamide Hydrochloride; Diabetosan; Diabex; Glucophage; Metiguanide; Glucoform; Glucomet; Glucomin; Glucomine; Orabet; Siamformet; Walaphage; Glumetza | C₄H₁₂ClN₅ | TRC [Internet]. [cited 2021 Apr 24]. Available from: https://www.trc-canada.com/product-detail/?M258815
Aljofan M, Riethmacher D. Anticancer activity of metformin: A systematic review of the literature. Futur Sci OA. 2019; 5(8). https://doi.org/10.2144/fsoa-2019-0053
Ugwueze C V, Ogamba OJ, Young EE, Onyenekwe BM, Ezeokpo BC. Review Article Metformin : A Possible Option in Cancer Chemotherapy. 2020; 2020. https://doi.org/10.1155/2020/7180923
Nicolini AC, Grisa TA, Wilker F, Gomes M, Rösing CK, Cavagni J. Effect of adjuvant use of metformin on periodontal treatment : a systematic review and meta-analysis. 2018; https://doi.org/10.1007/s00784-018-2666-9
Doxycycline hyclate | C24H33ClN2O10 - PubChem [Internet]. [cited 2021 Apr 24]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Doxycycline-hyclate
Doxycycline Hyclate Tablets, USP [Internet]. [cited 2021 Apr 24]. Available from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=ee45d9e1-65f7-4c6e-87cd-c9afc8eb85c4&type=display
Doxycycline hyclate | DrugBank Online [Internet]. [cited 2021 Apr 24]. Available from: https://go.drugbank.com/salts/DBSALT000896
Ali I, Alfarouk KO, Reshkin SJ, Ibrahim ME. Doxycycline as Potential Anti-cancer Agent. Anticancer Agents Med Chem. 2017; 17(12):1617-23. https://doi.org/10.2174/1871520617666170213111951
Hadjimichael AC, Foukas AF, Savvidou OD, Mavrogenis AF, Psyrri AK, Papagelopoulos PJ. The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review. Clin Sarcoma Res [Internet]. 2020; 10(1):1-10. https://doi.org/10.1186/s13569-020-00128-6
Srinath S. Management of periodontal disease with doxycycline: An update. Int J Pharm Clin Res. 2015; 7(4):252-5.
Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery - Full Text View - ClinicalTrials.gov [Internet]. [cited 2021 Jun 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT03076281
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer - Full Text View - ClinicalTrials.gov [Internet]. [cited 2021 Apr 29]. Available from: https://clinicaltrials.gov/ct2/show/NCT02874430?term=metformin+and+doxycycline&draw=2&rank=1
Oncology: Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer [Internet]. [cited 2021 Apr 30]. Available from: https://www.mdlinx.com/oncology/clinical-trials/clinical-trial-detail.cfm?nct_id=NCT02874430
Recommendations of the SEC (Antimicrobial & Antiviral) made in its 65th Meeting. 2020;2-4. Available from: https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadCommitteeFiles/65thAntimicrobial28jan20.pdf
Bhusnure OG, Dongare RB, Gholve SB, Rajmane T, B MA, Giram PS. Development and Validation of Uv Spectroscopic Method for the Determination of Metformin. 2012; 3(09):3170-4.
Judeh AABU, Sarief A, Umar Y, Ashwaq O, Haque SKM. NH H 3 C. 2020; 3:1-5.
Chhetri HP. 1, 2 ,. 2013; 4(7):2600-4.
Arayne MS, Sultana N, Zuberi MH. Development and validation of RP-HPLC method for the analysis of metformin. Pak J Pharm Sci. 2006; 19(3):231-5.
Fouad MM, Rashed NS. Development and validation of chromatographic and spectroscopic methods for estimation of repaglinide and metformin hcl in combined dosage form. J Glob Trends Pharm Sci J. 2014; 5(3):1844-8.
Majithia RH, Khodadiya DA, Patel VB. Spectrophotometric method development and validation for simultaneous estimation of Anagliptin and Metformin HCl BY Q - Absorption ratio method in synthetic mixture. Heliyon [Internet]. 2020; 6(5):e03855. https://doi.org/10.1016/j.heliyon.2020.e03855
Gedawy A, Al-Salami H, Dass CR. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide. J Food Drug Anal [Internet]. 2019; 27(1):315-22.
Kogawa AC, Salgado HRN. Quantification of doxycycline hyclate in tablets by ultraviolet spectrophotometric method. World Res J Pharm Res [Internet]. 2013; 1(2):21-4. Available from: http://www.bioinfopublication.org/jouarchive.php?opt=&jouid=BPJ0000294
Seth P, Stamm A. Quantitative estimation and separation of doxycycline hc1 and its related products. Drug Dev Ind Pharm. 1986; 12(10):1469-75. https://doi.org/10.3109/03639048609065871
Pourmoslemi S, Mirfakhraee S, Yaripour S, Mohammadi A. Development and validation of a stability-indicating RP-HPLC method for rapid determination of doxycycline in pharmaceutical bulk and dosage forms. Pharm Sci. 2016; 22(2):96-104. https://doi.org/10.15171/PS.2016.16
Oza MK, Patel SA. Simultaneous Spectrophotometric Determination of Doxycycline Monohydrate and Ornidazole in Synthetic Mixture. Int Res J Pharm. 2015; 6(4):265-8. https://doi.org/10.7897/2230-8407.06458
Lampiao F. International Journal of Medicine and Biomedical Research. Int J Med Biomed Res. 2014; 3(1):1-4. https://doi.org/10.14194/ijmbr.3.1.1
Saraei P, Asadi I, Kakar MA, Moradi-Kor N. The beneficial effects of metformin on cancer prevention and therapy: A comprehensive review of recent advances. Cancer Manag Res. 2019; 11:3295-313. https://doi.org/10.2147/CMAR.S200059
Doxycycline Treatment in Early Breast Cancer | Natural Medicine Journal [Internet]. [cited 2021 May 1]. Available from: https://www.naturalmedicinejournal.com/journal/2019-10/doxycycline-treatment-early-breast-cancer
ICH, Q2 (R1) validation of analytical procedures: text and methodology, Proceedings of the International Conference on Harmonization, November 1996
Published



How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).